New Blood Pressure Drug Shows Promise as a Gamechanger in Hypertension Treatment

A new drug, baxdrostat, has shown promising results in lowering blood pressure in patients with resistant hypertension, potentially reducing the risk of cardiovascular diseases. The phase III trial involving nearly 800 patients demonstrated significant blood pressure reductions, especially in difficult-to-treat cases, by blocking aldosterone production, a hormone that influences salt and water retention. This breakthrough could benefit up to half a billion people worldwide.